Takeda Has Been Delivering Life-Changing Treatments for 242 Years

Takeda: 242 Years of Life-Changing Treatments The story that began when Chobei Takeda started selling natural herbal medicines in Osaka, Japan in 1781 has made Takeda one of the world's largest pharmaceutical companies today. Committed to providing people and the world with a healthier and brighter future, Takeda continues its operations to create meaningful differences in patients' lives with over 50,000 employees in more than 80 countries. Takeda aims to discover and provide life-changing treatments in the therapeutic areas of Rare Genetic Diseases, Oncology, Immunology, Hematology and Gastroenterology, focusing on the rare needs of patients. Takeda contributes to the development of the healthcare value chain through research conducted with more than 200 business partners under the leadership of science, as well as investments in data and technology to develop innovative treatments and improve patient experience. Ömür Mangaloğlu, General Manager of Takeda Turkey, stating that they have been operating in Turkey since 2009, continued: "One of the most important reasons for Takeda's journey—which began as a family enterprise—transforming into a global value-creating organization worldwide is its strong commitment to its values. Our values of 'Integrity, Honesty, Justice and Perseverance' and our decision-making priorities—Patient-Trust-Reputation-Business, respectively—which have guided us for a quarter century, enable us to focus on unmet needs in patients' stories while also developing our own narratives. With our commitment to patients, our employees and the world, we develop innovative treatments by combining the experience provided by our deep heritage with innovation to enhance patients' quality of life. While creating an extraordinary experience for our employees, we also carry out corporate social responsibility initiatives that add value to the communities in which we operate. With our agile and dynamic team consisting of over 200 colleagues, we will continue to bring treatments developed globally to our patients in Turkey. I am proud to be part of an organization based on such a strong foundation, rich heritage and values."